The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry

MeSH terms

• Adult
• Aged
• Anemia / drug therapy
• Anemia / etiology
• Cardiovascular Diseases / epidemiology
• Cardiovascular Diseases / mortality
• Cardiovascular Diseases / prevention & control
• Erythropoietin / adverse effects
• Erythropoietin / therapeutic use*
• Female
• Hematocrit*
• Humans
• Italy / epidemiology
• Japan / epidemiology
• Kidney Failure, Chronic / mortality*
• Kidney Failure, Chronic / therapy*
• Male
• Middle Aged
• Morbidity
• Recombinant Proteins
• Registries
• Renal Replacement Therapy
• Risk Factors